ReP USP - Resultado da busca

Artigo de periodico
Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy (2025)
Villani Júnior, Adhemar; Freire, Maristela Pinheiro ; Lazar Neto, Felippe ; Lage, Luís Alberto de Pádua Covas ; Oliveira, Maura Salaroli de ; Abdala, Edson ; Marques, Fátima de Lourdes dos Santos Nunes ; Levin, Anna Sara Shafferman
Source: European Journal of Cancer. Unidades: FM, EACH
Assunto: LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLANI JÚNIOR, Adhemar et al. Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy. European Journal of Cancer, v. 223, p. 01-08, 2025Tradução . . Disponível em: http://dx.doi.org/10.1016/j.ejca.2025.115516. Acesso em: 25 out. 2025.
APA
Villani Júnior, A., Freire, M. P., Lazar Neto, F., Lage, L. A. de P. C., Oliveira, M. S. de, Abdala, E., et al. (2025). Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy. European Journal of Cancer, 223, 01-08. doi:10.1016/j.ejca.2025.115516
NLM
Villani Júnior A, Freire MP, Lazar Neto F, Lage LA de PC, Oliveira MS de, Abdala E, Marques F de L dos SN, Levin ASS. Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy [Internet]. European Journal of Cancer. 2025 ; 223 01-08.[citado 2025 out. 25 ] Available from: http://dx.doi.org/10.1016/j.ejca.2025.115516
Vancouver
Villani Júnior A, Freire MP, Lazar Neto F, Lage LA de PC, Oliveira MS de, Abdala E, Marques F de L dos SN, Levin ASS. Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy [Internet]. European Journal of Cancer. 2025 ; 223 01-08.[citado 2025 out. 25 ] Available from: http://dx.doi.org/10.1016/j.ejca.2025.115516
Trabalho de evento-resumo periodico
Investigation of the possible relationship of cancer stem cell subpopulation and metastatic potential of an oral squamous cell carcinoma cell line (2016)
Lopes, N. Martins; Alavarce, Rafaela Alves da Silva; Ortiz, Rafael Carneiro ; Dionisio, Thiago José ; Garlet, Gustavo Pompermaier ; Graner, E.; Lara, Vanessa Soares ; Rodini, Camila de Oliveira
Source: European Journal of Cancer. Conference titles: Biennial Congress of the European Association for Cancer Research. Unidade: FOB
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS BUCAIS, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, N. Martins et al. Investigation of the possible relationship of cancer stem cell subpopulation and metastatic potential of an oral squamous cell carcinoma cell line. European Journal of Cancer. Oxford: Faculdade de Odontologia de Bauru, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0959-8049(16)61347-3. Acesso em: 25 out. 2025. , 2016
APA
Lopes, N. M., Alavarce, R. A. da S., Ortiz, R. C., Dionisio, T. J., Garlet, G. P., Graner, E., et al. (2016). Investigation of the possible relationship of cancer stem cell subpopulation and metastatic potential of an oral squamous cell carcinoma cell line. European Journal of Cancer. Oxford: Faculdade de Odontologia de Bauru, Universidade de São Paulo. doi:10.1016/S0959-8049(16)61347-3
NLM
Lopes NM, Alavarce RA da S, Ortiz RC, Dionisio TJ, Garlet GP, Graner E, Lara VS, Rodini C de O. Investigation of the possible relationship of cancer stem cell subpopulation and metastatic potential of an oral squamous cell carcinoma cell line [Internet]. European Journal of Cancer. 2016 ; 61 S99.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/S0959-8049(16)61347-3
Vancouver
Lopes NM, Alavarce RA da S, Ortiz RC, Dionisio TJ, Garlet GP, Graner E, Lara VS, Rodini C de O. Investigation of the possible relationship of cancer stem cell subpopulation and metastatic potential of an oral squamous cell carcinoma cell line [Internet]. European Journal of Cancer. 2016 ; 61 S99.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/S0959-8049(16)61347-3
Artigo de periodico
Validation of methylation markers for diagnosis of oral cavity cancer (2015)
Arantes, L. M. R. B; Carvalho, A. C. de; Melendez, M. E; Centrone, Cristiane de Campos; Góis-Filho, J. F; Toporcov, Tatiana Natasha ; Caly, D. N; Tajara, E. H; Goloni-Bertollo, E M; Carvalho, A. L
Source: European Journal of Cancer. Unidade: FSP
Subjects: BIOMARCADORES, CARCINOMA DE CÉLULAS ESCAMOSAS, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARANTES, L. M. R. B et al. Validation of methylation markers for diagnosis of oral cavity cancer. European Journal of Cancer, v. 51, n. 5, p. 632-641, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2015.01.060. Acesso em: 25 out. 2025.
APA
Arantes, L. M. R. B., Carvalho, A. C. de, Melendez, M. E., Centrone, C. de C., Góis-Filho, J. F., Toporcov, T. N., et al. (2015). Validation of methylation markers for diagnosis of oral cavity cancer. European Journal of Cancer, 51( 5), 632-641. doi:10.1016/j.ejca.2015.01.060
NLM
Arantes LMRB, Carvalho AC de, Melendez ME, Centrone C de C, Góis-Filho JF, Toporcov TN, Caly DN, Tajara EH, Goloni-Bertollo EM, Carvalho AL. Validation of methylation markers for diagnosis of oral cavity cancer [Internet]. European Journal of Cancer. 2015 ; 51( 5): 632-641.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.01.060
Vancouver
Arantes LMRB, Carvalho AC de, Melendez ME, Centrone C de C, Góis-Filho JF, Toporcov TN, Caly DN, Tajara EH, Goloni-Bertollo EM, Carvalho AL. Validation of methylation markers for diagnosis of oral cavity cancer [Internet]. European Journal of Cancer. 2015 ; 51( 5): 632-641.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.01.060
Artigo de periodico
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia (2015)
Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Lopes, Matheus Rodrigues; Morini, Beatriz Corey; Traina, Fabíola; Costa, Fernando Ferreira; Saad, Sara Teresinha Olalla; Favaro, Patricia
Source: European Journal of Cancer. Unidade: FMRP
Subjects: LEUCEMIA, LINFOMA, LINHAGEM CELULAR, FÁRMACOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, João Kleber Novais et al. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, v. 51, n. 14, p. 2076–2085, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2015.07.018. Acesso em: 25 out. 2025.
APA
Pereira, J. K. N., Machado Neto, J. A., Lopes, M. R., Morini, B. C., Traina, F., Costa, F. F., et al. (2015). Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, 51( 14), 2076–2085. doi:10.1016/j.ejca.2015.07.018
NLM
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Vancouver
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Artigo de periodico
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy (2015)
Ruff, Paul; Ferry, David R.; Lakomỳ, Radek; McWalter, Gael; Van Hazel, Guy A.; Hoff, Paulo M.; Cunningham, David; Arnold, Dirk; Schmoll, Hans J.; Moiseyenko, Vladimir M.; McKendrick, Joseph J.; ten Tije, Albert J.; Vishwanath, Raghu L.; Bhargava, Pankaj; Chevalier, Soazig; Macarulla, Teresa; Cutsem, Eric Van
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), FATORES DE CRESCIMENTO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUFF, Paul et al. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, v. 51, n. 1, p. 18-26, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2014.10.019. Acesso em: 25 out. 2025.
APA
Ruff, P., Ferry, D. R., Lakomỳ, R., McWalter, G., Van Hazel, G. A., Hoff, P. M., et al. (2015). Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, 51( 1), 18-26. doi:10.1016/j.ejca.2014.10.019
NLM
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Vancouver
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Trabalho de evento-resumo periodico
Nifuroxazde halogenic derivatives induce ROS-mediated apoptosis and display antitumor activity against metastatic melanoma (2014)
Fernandez de Farias, C; Massaoka, Mariana Hiromi; Girola, N; Figueiredo, C. R; Azevedo, R. A; Tavares, Leoberto Costa ; Travassos, L. R
Source: European Journal of Cancer. Conference titles: EORTC - NCI - AACR Symposium on Molecular Targets and Cancer Therapeutics. Unidade: FCF
Subjects: MELANOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDEZ DE FARIAS, C et al. Nifuroxazde halogenic derivatives induce ROS-mediated apoptosis and display antitumor activity against metastatic melanoma. European Journal of Cancer. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 25 out. 2025. , 2014
APA
Fernandez de Farias, C., Massaoka, M. H., Girola, N., Figueiredo, C. R., Azevedo, R. A., Tavares, L. C., & Travassos, L. R. (2014). Nifuroxazde halogenic derivatives induce ROS-mediated apoptosis and display antitumor activity against metastatic melanoma. European Journal of Cancer. Oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Fernandez de Farias C, Massaoka MH, Girola N, Figueiredo CR, Azevedo RA, Tavares LC, Travassos LR. Nifuroxazde halogenic derivatives induce ROS-mediated apoptosis and display antitumor activity against metastatic melanoma. European Journal of Cancer. 2014 ; 50 26 res. 64.[citado 2025 out. 25 ]
Vancouver
Fernandez de Farias C, Massaoka MH, Girola N, Figueiredo CR, Azevedo RA, Tavares LC, Travassos LR. Nifuroxazde halogenic derivatives induce ROS-mediated apoptosis and display antitumor activity against metastatic melanoma. European Journal of Cancer. 2014 ; 50 26 res. 64.[citado 2025 out. 25 ]
Trabalho de evento-resumo periodico
IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells (2014)
Carneiro Lobo, Tatiana Correa; Salviatto, Armando Padilha; Baldwin, Albert S; Bassères, Daniela Sanchez
Source: European Journal of Cancer. Conference titles: EORTC - NCI - AACR Symposium on Molecular Targets and Cancer Therapeutics. Unidade: IQ
Subjects: ONCOGENES, NEOPLASIAS DO TRATO RESPIRATÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARNEIRO LOBO, Tatiana Correa et al. IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo. . Acesso em: 25 out. 2025. , 2014
APA
Carneiro Lobo, T. C., Salviatto, A. P., Baldwin, A. S., & Bassères, D. S. (2014). IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo.
NLM
Carneiro Lobo TC, Salviatto AP, Baldwin AS, Bassères DS. IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells. European Journal of Cancer. 2014 ; 50 103 res. 317.[citado 2025 out. 25 ]
Vancouver
Carneiro Lobo TC, Salviatto AP, Baldwin AS, Bassères DS. IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells. European Journal of Cancer. 2014 ; 50 103 res. 317.[citado 2025 out. 25 ]
Trabalho de evento-resumo periodico
Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity (2014)
Santos, Edmilson Ozorio dos; Aoki, Mateus Nobrega; Levantini, Elena; Bassères, Daniela Sanchez
Source: European Journal of Cancer. Conference titles: EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Unidade: IQ
Subjects: ONCOGENES, NEOPLASIAS DO TRATO RESPIRATÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Edmilson Ozorio dos et al. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo. . Acesso em: 25 out. 2025. , 2014
APA
Santos, E. O. dos, Aoki, M. N., Levantini, E., & Bassères, D. S. (2014). Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. Oxford: Instituto de Química, Universidade de São Paulo.
NLM
Santos EO dos, Aoki MN, Levantini E, Bassères DS. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. 2014 ; 50 129 res. 405.[citado 2025 out. 25 ]
Vancouver
Santos EO dos, Aoki MN, Levantini E, Bassères DS. Aurora kinases A and B are required for KRAS-induced lung cell oncogenicity. European Journal of Cancer. 2014 ; 50 129 res. 405.[citado 2025 out. 25 ]
Trabalho de evento-resumo periodico
Long-term outcome fractionated stereonated stereotatic radiotherapy and radiosurgery for treatment of symptomatic cavernous sinus meningioma: a 15-year experience (2013)
Marta, G; Correa, S. F. M.; Teixeira, Manoel Jacobsen
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: MENGIOMA, ESTUDOS RETROSPECTIVOS, BIÓPSIA, DOENÇAS CEREBRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTA, G e CORREA, S. F. M. e TEIXEIRA, Manoel Jacobsen. Long-term outcome fractionated stereonated stereotatic radiotherapy and radiosurgery for treatment of symptomatic cavernous sinus meningioma: a 15-year experience. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Marta, G., Correa, S. F. M., & Teixeira, M. J. (2013). Long-term outcome fractionated stereonated stereotatic radiotherapy and radiosurgery for treatment of symptomatic cavernous sinus meningioma: a 15-year experience. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Marta G, Correa SFM, Teixeira MJ. Long-term outcome fractionated stereonated stereotatic radiotherapy and radiosurgery for treatment of symptomatic cavernous sinus meningioma: a 15-year experience [Internet]. European Journal of Cancer. 2013 ; 49 S784.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Marta G, Correa SFM, Teixeira MJ. Long-term outcome fractionated stereonated stereotatic radiotherapy and radiosurgery for treatment of symptomatic cavernous sinus meningioma: a 15-year experience [Internet]. European Journal of Cancer. 2013 ; 49 S784.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Palliative chemotherapy in patients with malignant bowel obstruction (2013)
Muniz, D. Q.; Mak, M. P.; Bitton, R. C.; Takahasi, T. K.; Saragiotto, D. F.; Abdo, E.; Sabbaga, J.; Hoff, Paulo Marcelo Gehm
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: NEOPLASIAS DO GENITAIS FEMININOS (CIRURGIA;TERAPIA), NEOPLASIAS DO SISTEMA DISGESTÓRIO, TERAPIAS COMPLEMENTARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MUNIZ, D. Q. et al. Palliative chemotherapy in patients with malignant bowel obstruction. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Muniz, D. Q., Mak, M. P., Bitton, R. C., Takahasi, T. K., Saragiotto, D. F., Abdo, E., et al. (2013). Palliative chemotherapy in patients with malignant bowel obstruction. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Muniz DQ, Mak MP, Bitton RC, Takahasi TK, Saragiotto DF, Abdo E, Sabbaga J, Hoff PMG. Palliative chemotherapy in patients with malignant bowel obstruction [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Muniz DQ, Mak MP, Bitton RC, Takahasi TK, Saragiotto DF, Abdo E, Sabbaga J, Hoff PMG. Palliative chemotherapy in patients with malignant bowel obstruction [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors: should it be different in elderly? (2013)
Martins, R.; Cecotti, Henrique C; Pierrotti, Lígia Camera ; Abdala, E.; Hoff, Paulo Marcelo Gehm; Castro, G.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: NEOPLASIAS (RADIOTERAPIA), FATORES DE RISCO, FEBRE (ETIOLOGIA), ANTIBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, R. et al. Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors: should it be different in elderly?. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Martins, R., Cecotti, H. C., Pierrotti, L. C., Abdala, E., Hoff, P. M. G., & Castro, G. (2013). Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors: should it be different in elderly? European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Martins R, Cecotti HC, Pierrotti LC, Abdala E, Hoff PMG, Castro G. Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S272.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Martins R, Cecotti HC, Pierrotti LC, Abdala E, Hoff PMG, Castro G. Risk factors for severe complications during febrile neutropenic episodes in patients with solid tumors: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S272.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? (2013)
Caires, I. Q. S.; Lima, R. Caires; Souza, R. Barroso; Souza, K. T.; Negrão, M. V.; Carvalho, H.; Abdo Filho, E.; Hoff, Paulo Marcelo Gehm; Diz, M. D. E.P.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: IDOSOS, NEOPLASIAS DE CABEÇA E PESCOÇO, ESTUDOS RESTROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAIRES, I. Q. S. et al. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly?. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Caires, I. Q. S., Lima, R. C., Souza, R. B., Souza, K. T., Negrão, M. V., Carvalho, H., et al. (2013). Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Caires IQS, Lima RC, Souza RB, Souza KT, Negrão MV, Carvalho H, Abdo Filho E, Hoff PMG, Diz MDEP. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S722.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Caires IQS, Lima RC, Souza RB, Souza KT, Negrão MV, Carvalho H, Abdo Filho E, Hoff PMG, Diz MDEP. Definitive chemoradiotherapy (CRT) for advanced cancer (CC)0: should it be different in elderly? [Internet]. European Journal of Cancer. 2013 ; 49 S722.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Expression level of HOX genes is higher in human medulloblastoma tumorigenic cell line than in non-tumorigenic cell lines (2013)
Silva, R. Bonfim; Pimentel, T. V. C. A.; Valera, Elvis Terci; Ramalho, Fernando Silva; Machado, Hélio Rubens; Covas, Dimas Tadeu; Riggins, G. J.; Cardoso, A. A.; Fontes, Aparecida Maria
Source: European Journal of Cancer. Conference titles: European Cancer Congress on Reinforcing Multidisciplinarity (ESTRO). Unidade: FMRP
Subjects: CÉLULAS CULTIVADAS DE TUMOR, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, R. Bonfim et al. Expression level of HOX genes is higher in human medulloblastoma tumorigenic cell line than in non-tumorigenic cell lines. European Journal of Cancer. Kidlington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 25 out. 2025. , 2013
APA
Silva, R. B., Pimentel, T. V. C. A., Valera, E. T., Ramalho, F. S., Machado, H. R., Covas, D. T., et al. (2013). Expression level of HOX genes is higher in human medulloblastoma tumorigenic cell line than in non-tumorigenic cell lines. European Journal of Cancer. Kidlington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Silva RB, Pimentel TVCA, Valera ET, Ramalho FS, Machado HR, Covas DT, Riggins GJ, Cardoso AA, Fontes AM. Expression level of HOX genes is higher in human medulloblastoma tumorigenic cell line than in non-tumorigenic cell lines. European Journal of Cancer. 2013 ; 49 S779.[citado 2025 out. 25 ]
Vancouver
Silva RB, Pimentel TVCA, Valera ET, Ramalho FS, Machado HR, Covas DT, Riggins GJ, Cardoso AA, Fontes AM. Expression level of HOX genes is higher in human medulloblastoma tumorigenic cell line than in non-tumorigenic cell lines. European Journal of Cancer. 2013 ; 49 S779.[citado 2025 out. 25 ]
Trabalho de evento-resumo periodico
Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy (2013)
Braghiroli, M.; Dib, L.; Miranda, V.; Siqueira, S.; Hoff, Paulo Marcelo Gehm; Riechelmann, R.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: ANTINEOPLÁSICOS, METÁSTASE NEOPLÁSICA, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGHIROLI, M. et al. Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Braghiroli, M., Dib, L., Miranda, V., Siqueira, S., Hoff, P. M. G., & Riechelmann, R. (2013). Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Braghiroli M, Dib L, Miranda V, Siqueira S, Hoff PMG, Riechelmann R. Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy [Internet]. European Journal of Cancer. 2013 ; 49 S627.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Braghiroli M, Dib L, Miranda V, Siqueira S, Hoff PMG, Riechelmann R. Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy [Internet]. European Journal of Cancer. 2013 ; 49 S627.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Artigo de periodico
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib (2013)
Smith, John C.; Brooks, Laura; Hoff, Paulo M.; McWalter, Gael; Dearden, Simon; Morgan, Shethah R.; Wilson, David; Robertson, Jane D.; Jürgensmeier, Juliane M.
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (QUIMIOTERAPIA), MUTAÇÃO GENÉTICA, ESTUDOS RETROSPECTIVOS, PROGNÓSTICO, BIOMARCADORES, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SMITH, John C. et al. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer, v. 49, n. 10, p. 2424-2432, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2013.02.023. Acesso em: 25 out. 2025.
APA
Smith, J. C., Brooks, L., Hoff, P. M., McWalter, G., Dearden, S., Morgan, S. R., et al. (2013). KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib. European Journal of Cancer, 49( 10), 2424-2432. doi:10.1016/j.ejca.2013.02.023
NLM
Smith JC, Brooks L, Hoff PM, McWalter G, Dearden S, Morgan SR, Wilson D, Robertson JD, Jürgensmeier JM. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib [Internet]. European Journal of Cancer. 2013 ; 49( 10): 2424-2432.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2013.02.023
Vancouver
Smith JC, Brooks L, Hoff PM, McWalter G, Dearden S, Morgan SR, Wilson D, Robertson JD, Jürgensmeier JM. KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib [Internet]. European Journal of Cancer. 2013 ; 49( 10): 2424-2432.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2013.02.023
Trabalho de evento-resumo periodico
Malignancy-related hypercalcemia in the bishosphonate era (2013)
Alves, M. F. S.; Mak, M. P.; Piotto, G. H. M.; Takahasi, T. K.; Ramos, R. E. O; Fonseca, L. G.; Mano, Max Senna; Hoff, Paulo Marcelo Gehm; Castro Junior, G.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: CÁLCIO (ANORMALIDADES), NEOPLASIAS DE CABEÇA E PESCOÇO, CARCINOMA DE CÉLULAS ESCAMOSAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, M. F. S. et al. Malignancy-related hypercalcemia in the bishosphonate era. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Alves, M. F. S., Mak, M. P., Piotto, G. H. M., Takahasi, T. K., Ramos, R. E. O., Fonseca, L. G., et al. (2013). Malignancy-related hypercalcemia in the bishosphonate era. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Alves MFS, Mak MP, Piotto GHM, Takahasi TK, Ramos REO, Fonseca LG, Mano MS, Hoff PMG, Castro Junior G. Malignancy-related hypercalcemia in the bishosphonate era [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Alves MFS, Mak MP, Piotto GHM, Takahasi TK, Ramos REO, Fonseca LG, Mano MS, Hoff PMG, Castro Junior G. Malignancy-related hypercalcemia in the bishosphonate era [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy? (2013)
Crosara, M. A. T.; Marques, D. F.; Ferrari, A. C.; Alves, M. F. S.; Alex, A. K.; Sabbaga, J.; Hoff, Paulo Marcelo Gehm; Riechelmann, R.
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: REGRESSÃO LOGÍSTICA, NEOPLASIAS COLORRETAIS (QUIMIOTERAPIA), PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CROSARA, M. A. T. et al. Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Crosara, M. A. T., Marques, D. F., Ferrari, A. C., Alves, M. F. S., Alex, A. K., Sabbaga, J., et al. (2013). Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy? European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Crosara MAT, Marques DF, Ferrari AC, Alves MFS, Alex AK, Sabbaga J, Hoff PMG, Riechelmann R. Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy? [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Crosara MAT, Marques DF, Ferrari AC, Alves MFS, Alex AK, Sabbaga J, Hoff PMG, Riechelmann R. Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy? [Internet]. European Journal of Cancer. 2013 ; 49 S288.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
Initial results of stereotatic linear accelerator based irradiation for pituitary adenoma (2013)
Campos, A. de; Musolino, N. R. C; Cunha Neto, M. B. C; Leal, S. C.; Cescato, V. A. S.; Carvalho, I. T.; Villar,R. C.; Nadalin, Wladimir; Weltman, Eduardo
Source: European Journal of Cancer. Conference titles: European Cancer Congress 2013 Abstract Book. Unidade: FM
Subjects: ADENOMA (RADIOTERAPIA), IMAGEM POR RESSONÂNCIA MAGNÉTICA, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, A. de et al. Initial results of stereotatic linear accelerator based irradiation for pituitary adenoma. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529. Acesso em: 25 out. 2025. , 2013
APA
Campos, A. de, Musolino, N. R. C., Cunha Neto, M. B. C., Leal, S. C., Cescato, V. A. S., Carvalho, I. T., et al. (2013). Initial results of stereotatic linear accelerator based irradiation for pituitary adenoma. European Journal of Cancer. Oxford: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
NLM
Campos A de, Musolino NRC, Cunha Neto MBC, Leal SC, Cescato VAS, Carvalho IT, Villar RC, Nadalin W, Weltman E. Initial results of stereotatic linear accelerator based irradiation for pituitary adenoma [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Vancouver
Campos A de, Musolino NRC, Cunha Neto MBC, Leal SC, Cescato VAS, Carvalho IT, Villar RC, Nadalin W, Weltman E. Initial results of stereotatic linear accelerator based irradiation for pituitary adenoma [Internet]. European Journal of Cancer. 2013 ; 49 S281.[citado 2025 out. 25 ] Available from: http://ac.els-cdn.com/S0959804913700650/1-s2.0-S0959804913700650-main.pdf?_tid=a8f83b16-6324-11e3-9150-00000aab0f27&acdnat=1386849665_90687616a383bd3e643068fed7140529
Trabalho de evento-resumo periodico
SET protects mitochondria from apoptosis signaling and favors autophagy in HNSCC cells exposed to a pro-oxidant (2012)
Pestana, C. R.; Leopoldino, Andréia Machado; Curti, Carlos
Source: European Journal of Cancer. Conference titles: Biennial Congress of the European Association for Cancer Research. Unidade: FCFRP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, PROTEÍNAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PESTANA, C. R. e LEOPOLDINO, Andréia Machado e CURTI, Carlos. SET protects mitochondria from apoptosis signaling and favors autophagy in HNSCC cells exposed to a pro-oxidant. European Journal of Cancer. Kidlington: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 25 out. 2025. , 2012
APA
Pestana, C. R., Leopoldino, A. M., & Curti, C. (2012). SET protects mitochondria from apoptosis signaling and favors autophagy in HNSCC cells exposed to a pro-oxidant. European Journal of Cancer. Kidlington: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Pestana CR, Leopoldino AM, Curti C. SET protects mitochondria from apoptosis signaling and favors autophagy in HNSCC cells exposed to a pro-oxidant. European Journal of Cancer. 2012 ; 48 S148.[citado 2025 out. 25 ]
Vancouver
Pestana CR, Leopoldino AM, Curti C. SET protects mitochondria from apoptosis signaling and favors autophagy in HNSCC cells exposed to a pro-oxidant. European Journal of Cancer. 2012 ; 48 S148.[citado 2025 out. 25 ]
Artigo de periodico
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer (2012)
Ferrarotto, Renata; Machado, Karime; Mak, Milena P.; Shah, Neeraj; Takahashi, Tiago K.; Costa, Frederico P.; Overman, Michael J.; Kopetz, Scott; Hoff, Paulo M.
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, ADENOCARCINOMA, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata et al. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer, v. 48, n. 6, p. 820-826, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2012.01.008. Acesso em: 25 out. 2025.
APA
Ferrarotto, R., Machado, K., Mak, M. P., Shah, N., Takahashi, T. K., Costa, F. P., et al. (2012). A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer. European Journal of Cancer, 48( 6), 820-826. doi:10.1016/j.ejca.2012.01.008
NLM
Ferrarotto R, Machado K, Mak MP, Shah N, Takahashi TK, Costa FP, Overman MJ, Kopetz S, Hoff PM. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer [Internet]. European Journal of Cancer. 2012 ; 48( 6): 820-826.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2012.01.008
Vancouver
Ferrarotto R, Machado K, Mak MP, Shah N, Takahashi TK, Costa FP, Overman MJ, Kopetz S, Hoff PM. A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancer [Internet]. European Journal of Cancer. 2012 ; 48( 6): 820-826.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2012.01.008

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Indexado em

Non normalized affiliation